CN104557525B - A kind of preparation method of ester - Google Patents

A kind of preparation method of ester Download PDF

Info

Publication number
CN104557525B
CN104557525B CN201410556855.2A CN201410556855A CN104557525B CN 104557525 B CN104557525 B CN 104557525B CN 201410556855 A CN201410556855 A CN 201410556855A CN 104557525 B CN104557525 B CN 104557525B
Authority
CN
China
Prior art keywords
behenic acid
glycerol
acid
compritol
ato
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410556855.2A
Other languages
Chinese (zh)
Other versions
CN104557525A (en
Inventor
王振国
黄扬兵
陈勇
钟少伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangdong HEC Pharmaceutical
Original Assignee
Guangdong HEC Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangdong HEC Pharmaceutical filed Critical Guangdong HEC Pharmaceutical
Priority to CN201410556855.2A priority Critical patent/CN104557525B/en
Publication of CN104557525A publication Critical patent/CN104557525A/en
Application granted granted Critical
Publication of CN104557525B publication Critical patent/CN104557525B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The present invention provides a kind of preparation method of pharmaceutic adjuvant Compritol 888 ATO, and Compritol 888 ATO is made including reacting in presence of an acid catalyst in mixed reaction solvent in a mixed reaction solvent of cyclohexane and n-heptane in method.Method of the invention can obtain the product for closing symbol pharmaceutic adjuvant quality standard by reaction conditions such as the dosage of control mixed solvent and ratio, reaction temperatures;And easily operated control, it is at low cost, it is suitable for industrialized production.

Description

A kind of preparation method of ester
Technical field
The present invention relates to a kind of preparation methods of pharmaceutic adjuvant, and in particular to the preparation method of Compritol 888 ATO belongs to Pharmaceutical technology field.
Background technique
Compritol 888 ATO be a kind of predominantly single Compritol 888 ATO (monoesters), two Compritol 888 ATOs (diester) and The mixture of tribehenin acid glyceride (three esters) is the long-chain fat acid glyceride to serve many purposes;It is a kind of non-ionic Surfactant has excellent biocompatibility, can be used as lubricant or controlled release agent is used for tablet, capsule, oral solution, can Improve the compressibility in tablet and capsule manufacture;Also there are the characteristics such as taste masking, chemoproection, anti-oxidation, anti-hydrolysis;It answers extensively For fields such as food, drug, cosmetics.
In the prior art, the method for preparing Compritol 888 ATO mainly has: with the hydroxyl of protective agent elder generation protected glycerol, then with Behenic acid (i.e. n-docosane acid) reaction, then hydrolysis deprotection obtain single Compritol 888 ATO;Or using protection One kettle way obtains single Compritol 888 ATO after the hydroxyl of agent protected glycerol;Or make catalyst using acid, alkali or metal oxide, And/or pyroreaction, make behenic acid and glycerol direct esterification and obtains Compritol 888 ATO;The product that these methods are prepared It is either mainly single Compritol 888 ATO or the mixture that pharmaceutic adjuvant requirement is not met for ester content.Behenic acid is positive 20 Two carbon alkanoic acids are a kind of long chain fatty acids, and esterification and the esterification of Short-Chain Fatty Acids have bigger difference;In addition, final product Color, impurity, content etc. are also vulnerable to the influence of factors.The method of prior art Compritol 888 ATO obtained is difficult to accord with Close the quality requirement of pharmaceutic adjuvant.The Compritol 888 ATO of high quality plays an important role to pharmaceutical preparation etc.;Therefore, it is necessary to grind The preparation method of Compritol 888 ATO is studied carefully, to obtain the product for the high quality that can satisfy pharmaceutical preparation requirement.
Summary of the invention
The present invention provides a kind of method for preparing Compritol 888 ATO, and method of the invention, which can obtain, meets pharmaceutic adjuvant The product of quality standard meets the requirement of preparation, and the easily operated control of method of the invention, at low cost, is suitable for industrialization Large-scale production.
In European Pharmacopoeia 7.5 editions (European Pharmacopoeia7.5), the quality of pharmaceutic adjuvant Compritol 888 ATO Ester content, acid value, the specific standards of the parameters such as saponification number are defined in standard;Wherein, to the content range of each ester, it is desirable that Dan Shan Yu acid glyceride content is 15%-23%, and two Compritol 888 ATO contents are 40%-60%, and tribehenin acid glyceride content is 21%-35%;Acid value is not higher than 4, and saponification number is within the scope of 145-165.
The present invention is intended to provide a kind of easily operated control, at low cost, it is suitable for industrialization large-scale production, symbol can be prepared The method for closing the Compritol 888 ATO of European Pharmacopoeia standard.
In the present invention, Compritol 888 ATO refers to including single Compritol 888 ATO, two Compritol 888 ATOs, tribehenin acid glycerol The mixture of ester.
A kind of method preparing Compritol 888 ATO includes: the hybrid reaction of behenic acid and glycerol in hexamethylene and normal heptane In solvent, in the presence of a catalyst, reaction obtains Compritol 888 ATO.
Inventor has found different types of reaction dissolvent, has biggish shadow to the ester content of final product Compritol 888 ATO It rings.Inventors have found that the mixed reaction solvent of hexamethylene and normal heptane meets acquisition the final product of pharmaceutic adjuvant quality requirement It is advantageous.The solvent volume of the hexamethylene and normal heptane ratio is 1:2-1:10.In some embodiments, the ring The solvent volume of hexane and normal heptane ratio is 1:3-1:5.
Inventor has found that the rate of reaction is related with the dosage of reaction dissolvent, the dosage of the reaction dissolvent are as follows: with behenyl Mole meter of acid, each mole of behenic acid, reaction dissolvent consumption 350mL-650mL;In some embodiments, it reacts Solvent usage is 450mL-550mL;In some embodiments, reaction dissolvent consumption 480mL-520mL.
During the reaction, moisture need to be removed to promote the generation of product.In some embodiments, it is removed using water segregator Moisture is removed, part reaction dissolvent is added in water segregator to maintain the amount of reaction dissolvent in reactor;It is added in water segregator The amount of reaction dissolvent is limited with being flowed into the reaction dissolvent in water segregator in reactor.
The catalyst be lewis acid catalyst, in some embodiments the catalyst be selected from p-methyl benzenesulfonic acid or Its hydrate, sodium bisulfate, the concentrated sulfuric acid, or combinations thereof.In some embodiments, the catalyst is p-methyl benzenesulfonic acid Or its hydrate.
The molar ratio of the catalyst and behenic acid is 0.03:1-0.1:1.In some embodiments, institute The molar ratio for stating catalyst and behenic acid is 0.055:1-0.065:1;In some embodiments, the catalyst Molar ratio with behenic acid is 0.058:1-0.062:1.
When inventor also found behenic acid and glycerine reaction, reaction temperature has larger impact to the quality of final product.Reaction Temperature is excessively high, is also easy to produce impurity, keeps coloured product deeper.The reaction temperature is 80 DEG C -110 DEG C;In some embodiments, Reaction temperature is 90 DEG C -110 DEG C;In some embodiments, reaction temperature is 93 DEG C -105 DEG C;In some embodiments, Reaction temperature is the temperature of reaction dissolvent reflux.
When reaction, the molar ratio of behenic acid and glycerol is 1:1-1:2.In some embodiments, behenic acid Molar ratio with glycerol is 1:1.1-1:1.5;In some embodiments, the molar ratio of behenic acid and glycerol For 1:1.1-1:1.3.
The reaction time of the behenic acid and glycerol is -15 hours 8 hours.In some embodiments, behenic acid Reaction time with glycerol is -13 hours 10 hours.
To remove the possibility complete behenic acid of unreacted mixed in product or the behenic acid and other impurity of decomposition, The quality for improving product, can wash preparation-obtained Compritol 888 ATO, be beaten, crystallization, repeatedly the purifying such as crystallization Operation.In some embodiments, product is purified using acetone, isopropyl ether, water or combinations thereof.Some specific In embodiment, product is purified using isopropyl ether.
In some embodiments, a kind of method preparing Compritol 888 ATO includes: behenic acid and glycerol in ring The in the mixed solvent of hexane and normal heptane, in the presence of p-methyl benzenesulfonic acid, reaction obtains Compritol 888 ATO.
In some embodiments, a kind of method preparing Compritol 888 ATO includes: behenic acid and glycerol in ring The in the mixed solvent of hexane and normal heptane obtains Compritol 888 ATO in 90 DEG C of -110 DEG C of reactions in the presence of p-methyl benzenesulfonic acid.
In some embodiments, a kind of method preparing Compritol 888 ATO includes: behenic acid and glycerol in ring The in the mixed solvent of hexane and normal heptane obtains Compritol 888 ATO in 93 DEG C of -105 DEG C of reactions in the presence of p-methyl benzenesulfonic acid; The volume ratio of the hexamethylene and normal heptane is 1:3-1:5;The molar ratio of p-methyl benzenesulfonic acid or its hydrate and behenic acid For 0.055:1-0.065:1.
In some embodiments, a kind of method preparing Compritol 888 ATO includes: behenic acid and glycerol in ring In the mixed reaction solvent of hexane and normal heptane, in the presence of p-methyl benzenesulfonic acid, under reaction dissolvent reflux temperature, reaction is obtained Compritol 888 ATO;The molar ratio of the behenic acid and glycerol is 1:1.1-1:1.5 or 1:1.1-1:1.3;The ring The volume ratio of hexane and normal heptane be 1:2-1:10 or 1:3-1:5, mixed reaction solvent dosage by behenic acid mole in terms of, often One mole of behenic acid, reaction dissolvent consumption are 450mL-550mL or 480mL-520mL;P-methyl benzenesulfonic acid or its hydrate with The molar ratio of behenic acid is 0.055:1-0.065:1 or 0.058:1-0.062:1;React obtained Compritol 888 ATO Purified with isopropyl ether.
Preparation method of the present invention, the ester content of the Compritol 888 ATO of acquisition, acid value, saponification number etc. meet Europe The quality requirement of pharmacopeia can be used for pharmaceutical preparation as pharmaceutic adjuvant;Preparation method of the invention, reaction temperature is low, energy consumption Low, highly-safe, easily operated control is suitable for industrialized production.
Specific embodiment
For a further understanding of the present invention, the following describes the present invention in detail with reference to examples.Wherein " monoesters " refers to Single Compritol 888 ATO;" diester " refers to two Compritol 888 ATOs;" three esters " refers to tribehenin acid glyceride.
Embodiment 1
In the reactor, 136.40g behenic acid, 44.60g glycerol, mono- water p-methyl benzenesulfonic acid of 4.60g, hexamethylene is added With the mixed solvent 200mL (volume ratio 1:4) of normal heptane, same mixed solvent 32mL is added in water segregator, stirs, is heated to Reflux;Fraction water device water-dividing back flow reaction -12 hours 11 hours, stops reaction;Reaction mixture is cooled to 60 DEG C, is added to It in 400mL ice water, stirs 1 hour, solid, filtering is precipitated;40 DEG C of obtained solid are dried in vacuo -10 hours 8 hours;Obtained solid It is mixed with 1000mL isopropyl ether, 20 DEG C -30 DEG C are stirred -1 hour 0.5 hour, filtering, and 35 DEG C of solid vacuum drying 20 are small When -24 hours;White products 150.35g, HPLC detection are obtained, ester content meets the requirements.
Embodiment 2
In the reactor, 136.40g behenic acid, 44.60g glycerol is added, ring is added in mono- water p-methyl benzenesulfonic acid of 4.60g Same mixed solvent 30mL is added in water segregator in the mixed solvent 225mL (volume ratio 1:4) of hexane and normal heptane, stirs, adds Heat extremely flows back;Fraction water device water-dividing back flow reaction -13 hours 12 hours, stops reaction;Mixed liquor is cooled to 60 DEG C, is added to It in the mixed liquor (volume ratio 1:4) of 450mL cold acetone and water, stirs 1 hour, filtering;40 DEG C of obtained solid vacuum drying 8 are small When;Obtained solid is mixed with 900mL isopropyl ether, and 25 DEG C -30 DEG C are stirred 1 hour, filtering, and 35 DEG C of solid are dried in vacuo 24 hours; White products 150.08g, HPLC detection are obtained, ester content meets the requirements.
Embodiment 3
In the reactor, 136.40g behenic acid, 50.00g glycerol is added, ring is added in mono- water p-methyl benzenesulfonic acid of 3.90g Same mixed solvent 25mL is added in water segregator in the mixed solvent 180mL (volume ratio 1:5) of hexane and normal heptane, stirs, adds Heat extremely flows back;Fraction water device water-dividing back flow reaction -14 hours 13 hours, stops reaction;Mixed liquor is cooled to 60 DEG C, is added to It in 400mL cold water, stirs -1.5 hours 1 hour, filtering;40 DEG C of obtained solid are dried in vacuo -10 hours 8 hours;Obtained solid It is mixed with 1100mL isopropyl ether, 20 DEG C are stirred 45 minutes, filtering, and 35 DEG C of solid are dried in vacuo 24 hours;Obtain white products 149.78g, HPLC detection, ester content meet the requirements.
Reference examples 1
In the reactor, 13.64g behenic acid, 4.46g glycerol is added, positive heptan is added in mono- water p-methyl benzenesulfonic acid of 0.46g Alkane 20mL, normal heptane 4mL is added in water segregator, and stirring is heated to flowing back;Fraction water device water-dividing, back flow reaction 11 hours -12 are small When, stop reaction;Mixed liquor is cooled to 60 DEG C, is added in 40mL cold water, is stirred 1 hour, solid, filtering is precipitated;Gained 40 DEG C of solid are dried in vacuo 8 hours;Obtained solid is mixed with 100mL isopropyl ether, and 20 DEG C are stirred 1 hour, filtering, obtained solid 35 DEG C vacuum drying -24 hours 20 hours;Obtain product 15.13g;HPLC detects ester content, monoester content < 15%.
Reference examples 2
In the reactor, 13.64g behenic acid, 4.46g glycerol is added, hexamethylene is added in mono- water p-methyl benzenesulfonic acid of 0.46g Alkane 20mL, hexamethylene 4mL is added in water segregator, and stirring is heated to flowing back;Fraction water device water-dividing, back flow reaction 11 hours -12 are small When, stop reaction;Mixed liquor is cooled to 60 DEG C, is added in 40mL cold water, is stirred 1 hour, solid, filtering, gained is precipitated 40 DEG C of solid are dried in vacuo 8 hours;Then obtained solid is mixed with 100mL isopropyl ether, and 20 DEG C are stirred -1 hour 0.5 hour, mistake Filter, 35 DEG C of solid are dried in vacuo -24 hours 20 hours;Obtain product 15.49g;HPLC detects ester content, monoester content > 23%.
Reference examples 3
In the reactor, 13.64g behenic acid, 4.46g glycerol is added, hexamethylene and positive heptan is added in 0.096g sodium hydroxide Same solvent 4mL stirring is added in water segregator, is heated to flowing back by the mixed solvent 20mL (volume ratio 1:4) of alkane;Water segregator point Water, back flow reaction 11 hours, the remaining big content of starting materials (behenic acid surplus > 10%) of HPLC detection discovery;It abandons.
Reference examples 4
In the reactor, 13.64g behenic acid, 4.46g glycerol is added, diformazan is added in mono- water p-methyl benzenesulfonic acid of 0.46g Benzene 20mL, dimethylbenzene 4mL is added in water segregator, and stirring is heated to 145 DEG C;Fraction water device water-dividing, 145 DEG C of reactions are 11 hours -12 small When, stop reaction;Mixed liquor is cooled to 60 DEG C, is added in 40mL cold water, is stirred 1 hour, solid, filtering, gained is precipitated 40 DEG C of solid are dried in vacuo -10 hours 8 hours;Then obtained solid is mixed with 100mL isopropyl ether, and 20 DEG C are stirred 0.5 hour -1 Hour, filtering, 35 DEG C of solid are dried in vacuo -24 hours 20 hours;Obtain yellow product 15.49g;HPLC detects ester content, monoesters Content < 15%.
The ester content of embodiment 4:HPLC detection product
According to the correlation technique of European Pharmacopoeia 7.5 editions (European Pharmacopoeia7.5), requirement, standard, detection All data.HPLC detects the ester content of each embodiment, reference examples products obtained therefrom, testing conditions are as follows:
Chromatographic column: 7mmx0.6m;Stationary phase: styrene-divinylbenzene copolymer;Partial size: 5 μm;Aperture: 10nm;Flowing Phase: tetrahydrofuran;Flow velocity: 1mL/min;Detector temperature: 40 DEG C;Column temperature: 40 DEG C;Detector: differential refraction;Sample volume: 40 μ L (when sample introduction, sample temperature control is at 35 DEG C or ready-to-use).
Testing result is as follows:
Product ester content (%) Monoesters Diester Three esters Acid value Saponification number
Acceptable standard (%) 15.0-23.0 40.0-60.0 21.0-35.0 ≤4.0 145-165
Embodiment 1 21.20 49.87 27.57 0.36 149
Embodiment 2 20.37 50.27 26.17 0.34 148
Embodiment 3 20.52 49.58 26.47 0.35 148
Reference examples 1 12.59 63.73 21.84 \ \
Reference examples 2 24.11 54.39 20.26 \ \
Reference examples 4 11.81 66.09 20.97 \ \
The above description of the embodiment is only used to help understand the method for the present invention and its core ideas.It should be pointed out that pair For those skilled in the art, without departing from the principle of the present invention, the present invention can also be carried out Some improvements and modifications, these improvements and modifications also fall within the scope of protection of the claims of the present invention.

Claims (9)

1. a kind of preparation method of Compritol 888 ATO, comprising: the hybrid reaction of behenic acid and glycerol in hexamethylene and normal heptane It in solvent, in the presence of a catalyst, reacts and obtains Compritol 888 ATO, the volume ratio of the hexamethylene and normal heptane is 1:2-1: 10;Wherein, the molar ratio of behenic acid and glycerol is 1:1-1:2;The catalyst is selected from p-methyl benzenesulfonic acid or its hydration Object, sodium bisulfate, one of concentrated sulfuric acid or a variety of.
2. according to the method described in claim 1, further including that Compritol 888 ATO is purified with isopropyl ether.
3. the volume ratio of preparation method according to claim 1 or 2, the hexamethylene and normal heptane is 1:3-1:5.
4. preparation method according to claim 1 or 2, the dosage of the mixed reaction solvent, by behenic acid mole in terms of, Each mole of behenic acid, reaction dissolvent consumption 350mL-650mL.
5. the molar ratio of preparation method according to claim 1 or 2, the catalyst and behenic acid is 0.03:1- 0.1:1。
6. the molar ratio of preparation method according to claim 1 or 2, behenic acid and glycerol is 1:1.1-1:1.5.
7. the reaction temperature of preparation method according to claim 1 or 2, behenic acid and glycerol is 90 DEG C -110 DEG C.
8. the reaction time of preparation method according to claim 1 or 2, behenic acid and glycerol is -15 hours 8 hours.
9. according to the method described in claim 1, including: the mixed reaction solvent of behenic acid and glycerol in hexamethylene and normal heptane In, in the presence of p-toluenesulfonic acid or its hydrate, behenyl acid glycerol is obtained within -13 hours 10 hours in 90 DEG C of -110 DEG C of reactions Ester;The molar ratio of the behenic acid and glycerol is 1:1.1-1:1.3;In the mixed reaction solvent, hexamethylene and normal heptane Volume ratio is 1:3-1:5, mixed reaction solvent dosage by behenic acid mole in terms of, each mole of behenic acid, reaction dissolvent consumption For 480mL-520mL;The molar ratio of the p-methyl benzenesulfonic acid or its hydrate and behenic acid is 0.058:1-0.062:1; Obtained Compritol 888 ATO is reacted to be purified with isopropyl ether.
CN201410556855.2A 2013-10-21 2014-10-20 A kind of preparation method of ester Active CN104557525B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410556855.2A CN104557525B (en) 2013-10-21 2014-10-20 A kind of preparation method of ester

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310495629 2013-10-21
CN2013104956293 2013-10-21
CN201410556855.2A CN104557525B (en) 2013-10-21 2014-10-20 A kind of preparation method of ester

Publications (2)

Publication Number Publication Date
CN104557525A CN104557525A (en) 2015-04-29
CN104557525B true CN104557525B (en) 2019-01-04

Family

ID=53074708

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410556855.2A Active CN104557525B (en) 2013-10-21 2014-10-20 A kind of preparation method of ester

Country Status (1)

Country Link
CN (1) CN104557525B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107417522B (en) * 2017-05-22 2020-11-06 武汉桀升生物科技有限公司 Method for catalytically synthesizing glyceryl behenate used as pharmaceutical adjuvant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010120910A (en) * 2008-11-21 2010-06-03 Kao Corp Method for producing glycerol monofatty acid ester
CN103102267A (en) * 2011-11-10 2013-05-15 江西阿尔法高科药业有限公司 Preparation method of pharmaceutic adjuvant grade Glyceryl Behenate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010120910A (en) * 2008-11-21 2010-06-03 Kao Corp Method for producing glycerol monofatty acid ester
CN103102267A (en) * 2011-11-10 2013-05-15 江西阿尔法高科药业有限公司 Preparation method of pharmaceutic adjuvant grade Glyceryl Behenate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Lik H.Wee et al..Synthesis of Monoglycerides by Esterification of Oleic Acid with Glycerol in Heterogeneous Catalytic Process Using Tin-Organic Framework Catalyst.《Catalysis Letters》.2013,第143卷(第4期),第356-363页.
Y. Pouilloux et al..Synthesis of glycerol monooctadecanoate from octadecanoic acid and glycerol. Influence of solvent on the catalytic properties of basic oxides.《C. R. Acad. Sci. Paris, Série IIc, Chimie : Chemistry》.2000,第3卷(第7期),第589-594页.
高纯度甘油单酯制备、性质及应用;周曙光;《日用化学工业》;19941231(第3期);第43-44、53页

Also Published As

Publication number Publication date
CN104557525A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
CN103923024B (en) A kind of process for purification of acipimox
CN101864019A (en) Preparation method of sodium polystyrene sulfonate ion exchange resin
CN104203896A (en) Method for the preparation of triglycerides of medium-chain length fatty acids
CN109575024A (en) A kind of matrine phenolate and the preparation method and application thereof
CN104557525B (en) A kind of preparation method of ester
CN104177461A (en) Preparation method of troxerutin
CN103570530B (en) A kind of preparation method of anidulafungin side chain intermediate
CN102558124A (en) Method for preparing food-grade sodium dehydroacetate
CN104892909A (en) Preparation method of polyethyleneglycol monomethyl ether-polylactic acid block copolymer
CN101891784A (en) Method for synthesizing 3&#39;,4&#39;,7-troxerutin
CN102248622A (en) Capsule mold release agent and preparation method thereof
CN108586250A (en) A kind of sodium stearyl fumarate auxiliary material and preparation method thereof
CN103420979B (en) The process for purification of Esomeprazole sodium
CN102277237B (en) Preparation method of high-purity glyceride type fish oil
CN105175317B (en) A kind of method for preparing picosulfate sodium
CN110423186A (en) A method of producing phloroglucin
CN109400432A (en) The preparation method and application of hydroxytyrosol ester type compound
CN102198402A (en) Cu-Pd-Mg-Al four-component catalyst for preparing 1,2-propylene glycol (1,2-PDO) by hydrogenation of biodiesel-based crude glycerin as well as preparation method thereof
CN105001256B (en) The preparation method of Choline Glycerophosphate crystal
CN105175316B (en) A kind of method for preparing laxative picosulfate sodium
CN108440630A (en) The preparation process of phytosterols oletate
CN102690212A (en) Preparation method of iodixanol
CN111574386B (en) Purification method of oxoethylamine compound
CN107417522B (en) Method for catalytically synthesizing glyceryl behenate used as pharmaceutical adjuvant
WO2019237327A1 (en) Method for producing phloroglucinol

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 523808 No.1, Gongye North Road, Songshanhu Park, Dongguan City, Guangdong Province

Patentee after: Guangdong Dongyangguang Pharmaceutical Co.,Ltd.

Address before: 523808 No. 1 Industrial North Road, Songshan Industrial Park, Songshan, Guangdong, Dongguan, Hubei

Patentee before: SUNSHINE LAKE PHARMA Co.,Ltd.